[{"address1": "6200 Lookout Road", "city": "Boulder", "state": "CO", "zip": "80301", "country": "United States", "phone": "720 647 8519", "website": "https://www.enliventherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.", "fullTimeEmployees": 65, "companyOfficers": [{"maxAge": 1, "name": "Mr. Samuel S. Kintz M.B.A.", "age": 38, "title": "Co-Founder & Head of Pipeline", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 973800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph P. Lyssikatos Ph.D.", "age": 60, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 709400, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Helen Louise Collins M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 746400, "exercisedValue": 0, "unexercisedValue": 4612248}, {"maxAge": 1, "name": "Mr. Richard A. Fair", "age": 56, "title": "CEO, President & Director", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anish  Patel Pharm.D.", "age": 45, "title": "Co-Founder & COO", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin  Hohl", "age": 36, "title": "CFO & Head of Corporate Development", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 488500, "exercisedValue": 0, "unexercisedValue": 1212737}, {"maxAge": 1, "name": "Dr. Galya D. Blachman Esq., Ph.D.", "age": 48, "title": "Chief Legal Officer & Head of Business Development", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 26.99, "open": 27.45, "dayLow": 27.125, "dayHigh": 29.94, "regularMarketPreviousClose": 26.99, "regularMarketOpen": 27.45, "regularMarketDayLow": 27.125, "regularMarketDayHigh": 29.94, "payoutRatio": 0.0, "beta": 1.143, "forwardPE": -12.413503, "volume": 1067220, "regularMarketVolume": 1067220, "averageVolume": 1008420, "averageVolume10days": 889960, "averageDailyVolume10Day": 889960, "bid": 29.35, "ask": 29.52, "bidSize": 2, "askSize": 2, "marketCap": 1745998080, "fiftyTwoWeekLow": 13.3, "fiftyTwoWeekHigh": 29.98, "allTimeHigh": 250.84, "allTimeLow": 3.896, "fiftyDayAverage": 21.4347, "twoHundredDayAverage": 20.415924, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1268923008, "profitMargins": 0.0, "floatShares": 37525902, "sharesOutstanding": 59347317, "sharesShort": 9166736, "sharesShortPriorMonth": 8111262, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.1545, "heldPercentInsiders": 0.08239, "heldPercentInstitutions": 1.0222499, "shortRatio": 6.42, "shortPercentOfFloat": 0.2198, "impliedSharesOutstanding": 59347317, "bookValue": 8.034, "priceToBook": 3.6619365, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -97207000, "trailingEps": -1.81, "forwardEps": -2.37, "enterpriseToEbitda": -11.333, "52WeekChange": 0.25243616, "SandP52WeekChange": 0.120657206, "quoteType": "EQUITY", "currentPrice": 29.42, "targetHighPrice": 52.0, "targetLowPrice": 33.0, "targetMeanPrice": 41.375, "targetMedianPrice": 40.0, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 477564992, "totalCashPerShare": 8.047, "ebitda": -111972000, "totalDebt": 490000, "quickRatio": 32.598, "currentRatio": 32.948, "debtToEquity": 0.103, "returnOnAssets": -0.17623, "returnOnEquity": -0.25429, "freeCashflow": -45616124, "operatingCashflow": -71666000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ELVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Enliven Therapeutics, Inc.", "longName": "Enliven Therapeutics, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1770425711, "regularMarketTime": 1770411603, "exchange": "NMS", "messageBoardId": "finmb_693128628", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 9.00334, "regularMarketPrice": 29.42, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1584019800000, "postMarketChangePercent": -0.7138035, "postMarketPrice": 29.21, "postMarketChange": -0.21000099, "regularMarketChange": 2.43, "regularMarketDayRange": "27.125 - 29.94", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1008420, "fiftyTwoWeekLowChange": 16.119999, "fiftyTwoWeekLowChangePercent": 1.2120299, "fiftyTwoWeekRange": "13.3 - 29.98", "fiftyTwoWeekHighChange": -0.55999947, "fiftyTwoWeekHighChangePercent": -0.018679101, "fiftyTwoWeekChangePercent": 25.243616, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.81, "epsForward": -2.37, "epsCurrentYear": -1.8, "priceEpsCurrentYear": -16.344444, "fiftyDayAverageChange": 7.9853, "fiftyDayAverageChangePercent": 0.3725408, "twoHundredDayAverageChange": 9.004076, "twoHundredDayAverageChangePercent": 0.44103202, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Enliven Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]